Evidence map›Paper›PMID 35064060›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2022

Financial Hardship by Age at Diagnosis Including in Young Adulthood among African American Cancer Survivors.

Theresa A Hastert, Julie J Ruterbusch, Judith Abrams, Mrudula Nair, Angie S Wenzlaff, Jennifer L Beebe-Dimmer, Stephanie S Pandolfi, Ann G Schwartz

Open access · bronzeAbstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Financial concerns of adults with cancer using patient navigation services offered through employer-sponsored benefits.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Theresa A HastertDepartment of Oncology, Wayne State University School of Medicine, Detroit, Michigan.ORCID 0000-0001-6251-6422
Julie J RuterbuschDepartment of Oncology, Wayne State University School of Medicine, Detroit, Michigan.ORCID 0000-0001-8089-7409
Judith AbramsDepartment of Oncology, Wayne State University School of Medicine, Detroit, Michigan.
Mrudula NairDepartment of Oncology, Wayne State University School of Medicine, Detroit, Michigan.
Angie S WenzlaffDepartment of Oncology, Wayne State University School of Medicine, Detroit, Michigan.ORCID 0000-0001-8669-8240
Jennifer L Beebe-DimmerDepartment of Oncology, Wayne State University School of Medicine, Detroit, Michigan.
Stephanie S PandolfiDepartment of Oncology, Wayne State University School of Medicine, Detroit, Michigan.
Ann G SchwartzDepartment of Oncology, Wayne State University School of Medicine, Detroit, Michigan.ORCID 0000-0002-9525-1157
Wayne State University · US

Funding

Tumor Biology and Microenvironment (Program 1)P30CA022453 · NCI · WAYNE STATE UNIVERSITY · PI PAUL M STEMMER · 1985 to 2026
$68.4M
The impact of the COVID-19 pandemic on African American cancer survivors and their caregiversU01CA199240 · NCI · WAYNE STATE UNIVERSITY · PI Jennifer L Beebe-Dimmer, Ann G. Schwartz · 2017 to 2026
$15.2M
Reducing Cancer Health Disparities in DetroitP20CA262735 · NCI · WAYNE STATE UNIVERSITY · PI SCHWARTZ, ANN G. · 2021 to 2023
$3.0M
NCI NIH HHS HHSN261201000028CNCI NIH HHS P30 CA022453NCI NIH HHS U01 CA199240
6 · The paper itself

Abstract

backgroundFinancial hardship is most common among cancer survivors with the fewest financial resources at diagnosis; however, little is known about the financial outcomes of young adult (YA) survivors (ages 20-39 at diagnosis), despite their having fewer financial reserves than older adults.

methodsWe utilized data from 3,888 participants in the population-based Detroit Research on Cancer Survivors cohort. Participants self-reported several forms of material and behavioral financial hardship (MFH and BFH, respectively). Psychological financial hardship (PFH) was measured using the Comprehensive Score for financial Toxicity (COST) score. Modified Poisson models estimated prevalence ratios (PR) and 95% confidence intervals (CI) for financial hardship by age at diagnosis controlling for demographic, socioeconomic, and cancer-related factors.

resultsMFH prevalence was inversely associated with age such that 72% of YA survivors reported MFH, 62% ages 40 to 54, 49% ages 55 to 64, and 33% ages 65 to 79 (PRadjusted YA vs. 65+: 1.75; 95% CI, 1.49-2.04; Ptrend < 0.001). BFH was also more common among YA survivors (26%) than those ages 65 to 79 (20%; PRadjusted: 1.50; 95% CI, 1.08-2.08; Ptrend = 0.019). Age was positively associated with financial wellbeing. COST scores ranged from 20.7 (95% CI, 19.0-22.4) among YA survivors to 27.2 (95% CI, 26.1-28.2) among adults 65 to 79 years old (Ptrend < 0.001).

conclusionsIn this population of African American cancer survivors, MFH and BFH were more common, and PFH was more severe, in YA survivors compared with those diagnosed as older adults. IMPACT: Young adulthood at diagnosis should be considered a risk factor for cancer-related financial hardship and addressed in work designed to reduce the adverse financial impacts of cancer.

Indexed as

Cancer SurvivorsNeoplasmsAdultAgedBlack or African AmericanCost of IllnessFinancial StressHumansMiddle AgedPrevalenceYoung Adult

Identifiers

PMID35064060
PMCPMC9377160
OpenAlexW4207082048

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.